Obesity: The emerging neurobiology of calorie addiction
- Helmholtz Zentrum München, Germany
The increased availability and consumption of highly palatable foods is the major factor behind the rise of obesity and type 2 diabetes in developed countries. Many of these highly palatable foods are sweet tasting foods that contain high levels of the natural sugar sucrose. There are alternatives to sucrose—the artificial sweetener sucralose is 600 times sweeter and does not contain calories—but the obesity epidemic continues because we prefer sucrose to sucralose.
Progress has been made in recent years in understanding the neurobiological underpinnings for this preference: sucrose activates dopamine neurons in a region of the brain called the striatum, and the resulting release of dopamine is associated with pleasure (Velloso et al., 2008). Sucralose, on the other hand, does not have this effect. Moreover, the repeated consumption of high levels of sucrose can create a cycle of continued overconsumption—even compulsive eating—in order to recapture the initial feelings of pleasure. This is similar in many ways to drug abuse or addiction, and also involves some of the same signalling pathways within the body (Johnson and Kenny, 2010).
In 2011 Jeff Friedman of Rockefeller University and co-workers—including Ana Domingos as first author—used optogenetic techniques to show that activating dopamine neurons in the brain encouraged mice to eat in the absence of a sweet taste (Domingos et al., 2011). The mice preferred water to sugar if their dopamine neurons were activated at the same time that they were offered the water.
Now, in eLife, a team of researchers led by Domingos and Friedman reports that the release of dopamine is driven by melanin-concentrating hormone (MCH) neurons in the lateral hypothalamus of the brain (Domingos et al, 2013a). The experiments relied on transgenic mice in which the MCH neurons could be activated with a carefully directed light stimulus, and showed that mice preferred sucralose to sucrose when their MCH neurons had been activated. This finding was confirmed with mutant mice that lacked the cellular machinery required to recognize sweet tastes; these mice still preferred sucrose over sucralose because of its caloric content.
Friedman, Domingos (who is now at the Gulbenkian Science Institute in Portugal) and co-workers—who are based at Rockefeller, Yale, Albert Einstein College of Medicine, the JB Pierce Laboratory and UFRGS in Brazil—then engineered mice that did not have any MCH neurons at all. The fact that these mice preferred sucralose to sucrose supports a model in which MCH neurons appear to function as both a sucrose sensor and a nutrient sensor. Taken together, the results demonstrate that preference for sucrose is dependent on at least three factors: its ability to activate MCH neurons; its sweet taste as detected by the taste buds; and, as previously reported, the metabolic state of the organism. (Domingos et al., 2011; Domingos et al., 2013b). Consistent with these findings, they propose a model in which MCH neurons act as a key component of the neuronal networks that lead to the release of dopamine in response to the detection of sucrose (Figure 1).
Figure 1
Different responses to sucrose and sucralose.
Domingos et al. showed that sucrose activates melanin-concentrating hormone (MCH) neurons in the lateral hypothalamus (LH), which leads to the release of dopamine (DA) in the striatum: pathway shown in red. In contrast, sucralose can only induce the release of dopamine if optogenetic techniques are used to activate the MCH neurons; pathway shown in green. However, it is almost certain that various other neuronal pathways (shown by black dashed lines) are involved; these might include orexin/hypocretin (OX) neurons in the lateral hypothalamus, or other neurons elsewhere in the brain.
While this latest work shows that sucrose preference is based on its nutritive value, the actual molecular mechanisms via which it affects MCH neurons remains unknown. According to one report, since sucrose contains glucose, it could modulate the excitability of MCH neurons via potassium channels that are gated by ATP (Kong et al., 2010).
Domingos et al. now suggest that the activation of the MCH neurons by sucrose might be mediated indirectly by afferent nerve fibres originating from taste sensors in the taste buds and/or the gastrointestinal tract. The receptors that respond to sweet tastes also respond to the nutritional content of the food and help determine which neuropeptides should be released by taste buds (Geraedts and Munger, 2013). Moreover, sucrose, unlike sucralose, is known to act on taste receptors in the gastrointestinal tract (Steinert et al., 2011): this modulates the release of hormones which serve to inform the brain about the availability of calories in the body (Brown et al., 2011). Taken together, these data suggest that taste receptors in both the gustatory system (the part of the sensory system that responds to taste) and the gastrointestinal system may respond to natural sugars in one way, and to artificial sugars in a different way.
An outstanding challenge is to find out how MCH neurons activate dopamine neurons in the striatum. One possibility is that the orexin/hypocretin neurons in the hypothalamus have a role. Since these neurons are involved in the regulation of the desire for sugar (Cason and Aston-Jones, 2013), and they are also known to interact with MCH neurons (Guan et al., 2002), they might work together with MCH neurons to trigger reward.
The work of Domingos et al. represents a significant advance in our understanding of the neural mechanisms underlying how mammals respond to some kinds of foods. We now understand better why we have an innate desire for sweet foods, which are highly caloric and might have been, in the past, advantageous from an evolutionary perspective. Yet in the modern world, where highly caloric food is readily available, how do we resist this drive so as to avoid the many problems that are associated with obesity?
Interestingly, it appears that the increased use of non-caloric sugar substitutes as a mechanism to prevent weight gain or enhance weight loss has come at a cost. Recent studies show that prolonged consumption of sucralose and other high-intensity sweeteners can have potentially harmful effects on energy metabolism (Swithers et al., 2013; Simon et al., 2013). On the other hand, it has been reported that non-caloric sugar substitutes do little to reduce feelings of hunger (Brown et al., 2011).
By applying a combination of novel technologies to a question that nutrition researchers have been investigating for many years, Domingos et al. have discovered that a specific subset of neurons in the hypothalamus are essential for both calorie sensing and triggering the reward value associated with sucrose. A great deal of work is required to understand how this circuit relates to higher brain centres and other known nutrient-sensing cells. But thanks to the elegant studies by Domingos, Friedman and their co-workers, a door to that path has just been pushed wide open.
References
-
Role of orexin/hypocretin in conditioned sucrose-seeking in ratsPsychopharmacology 226:155–165.https://doi.org/10.1007/s00213-012-2902-y
-
Leptin regulates the reward value of nutrientNature Neuroscience 14:1562–1568.https://doi.org/10.1038/nn.2977
-
Artificial sweeteners stimulate adipogenesis and suppress lipolysis independently of sweet taste receptorsJournal of Biological Chemistry 288:32475–32489.https://doi.org/10.1074/jbc.M113.514034
-
Effects of carbohydrate sugars and artificial sweeteners on appetite and the secretion of gastrointestinal satiety peptidesBritish Journal of Nutrition 105:1320–1328.https://doi.org/10.1017/S000711451000512X
-
Diet-induced inflammation of the hypothalamus in obesityNeuroimmunomodulation 15:189–193.https://doi.org/10.1159/000153423
Article and author information
Author details
Publication history
Copyright
© 2014, García-Cáceres and Tschöp
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,162
- views
-
- 172
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Obesity: The emerging neurobiology of calorie addiction
eLife 3:e01928.
https://doi.org/10.7554/eLife.01928
Further reading
-
How is the brain able to tell the difference between natural sugar and artificial sweetener?
-
- Medicine
- Neuroscience
Pain after surgery causes significant suffering. Opioid analgesics cause severe side effects and accidental death. Therefore, there is an urgent need to develop non-opioid therapies for managing post-surgical pain. Local application of Clarix Flo (FLO), a human amniotic membrane (AM) product, attenuated established post-surgical pain hypersensitivity without exhibiting known side effects of opioid use in mice. This effect was achieved through direct inhibition of nociceptive dorsal root ganglion (DRG) neurons via CD44-dependent pathways. We further purified the major matrix component, the heavy chain-hyaluronic acid/pentraxin 3 (HC-HA/PTX3) from human AM that has greater purity and water solubility than FLO. HC-HA/PTX3 replicated FLO-induced neuronal and pain inhibition. Mechanistically, HC-HA/PTX3-induced cytoskeleton rearrangements to inhibit sodium current and high-voltage activated calcium current on nociceptive DRG neurons, suggesting it is a key bioactive component mediating pain relief. Collectively, our findings highlight the potential of naturally derived biologics from human birth tissues as an effective non-opioid treatment for post-surgical pain. Moreover, we unravel the underlying neuronal mechanisms of pain inhibition induced by FLO and HC-HA/PTX3.
